Versant Ventures VI GP-GP, LLC, 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 820,931 shares at $21.20 ($2.7M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $2.7M AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 684,143 | $0 | 0.0% |
| 2 | $19.89 | 10,952 | $218K | 8.1% |
| 3 | $19.89 | 10,952 | $218K | 8.1% |
| 4 | $21.20 | 3,900 | $83K | 3.1% |
| 5 | $22.17 | 1,000 | $22K | 0.8% |
| 6 | $19.18 | 3,100 |
| $59K |
| 2.2% |
| 7 | $20.27 | 100 | $2K | 0.1% |
| 8 | $17.68 | 4,968 | $88K | 3.3% |
| 9 | $17.68 | 4,968 | $88K | 3.3% |
| 10 | $18.32 | 6,101 | $112K | 4.2% |
| 11 | $18.32 | 6,101 | $112K | 4.2% |
| 12 | $19.93 | 42,323 | $843K | 31.4% |
| 13 | $19.93 | 42,323 | $843K | 31.4% |
| Total | $3.27 avg | 820,931 | $2.7M | 100% |
| Filing → |
| AKRO | SELL | 2020-01-15 | $1.8M | — | Filing → |
| AKRO | SELL | 2020-01-09 | $2.1M | — | Filing → |